Media Releases and Opportunities
» Go to news mainMedia opportunity: Dalhousie University researcher wins top prize for paper on her innovative research showing that reversing insulin resistance improves psychiatric outcomes in treatment‑resistant bipolar disorder
Dalhousie University physician Dr. Cindy Calkin is being honoured with a top psychiatry award for research that discovered a new way to address treatment-resistant bipolar disorder – by reversing insulin resistance. It is a novel approach that involves treating an underlying metabolic disorder to improve a psychiatric one, a concept that led to a paradigm shift in the field of psychiatry.
Dr. Calkin, a clinical researcher and associate professor of Psychiatry and Medical Neuroscience, will receive the 2023 Paul Wender Best Paper in The Journal of Clinical Psychiatry Award for her paper, Treating Insulin Resistance with Metformin as a Strategy to Improve Outcome in Treatment-Resistant Bipolar Disorder - the TRIO-BD study. It was selected by the American Society of Clinical Psychopharmacology Awards Committee.
The study showed that reversing insulin resistance improved treatment-resistant bipolar depression in patients who had been chronically ill for more than 25 years and failed eight to nine psychiatric medication trials over their lifetime. Their improvement was significant within six weeks of starting the drug Metformin, with patients remaining well throughout the 26-week trial.
Dr. Calkin and her team were the first to find high rates of insulin resistance in patients with bipolar disorder and that insulin resistance was independently linked to negative bipolar outcomes. As a result, the Canadian Diabetes Association updated its guidelines to include bipolar disorder as an independent risk factor for Type 2 diabetes. Dr. Calkin and her team have also published guidelines recommending that all patients with bipolar disorder be tested for insulin resistance.
Dr. Calkin is available to discuss her research, the award being presented today and how this work has given hope to even the sickest of those affected.
-30-
Media contact:
Alison Auld
Senior Research Reporter
Communications, Marketing and Creative Services
Dalhousie University
Cell: 1-902-220-0491
Email: alison.auld@dal.ca
Recent News
- Media Release: McCall MacBain Foundation Invests $3.5M to Expand Dalhousie Student Leadership Academy
- Media Release: Johnson Scholarship Foundation’s $1m+ gift boosts Dalhousie’s Faculty of Engineering efforts to diversify the profession
- Media opportunity: Dalhousie University researcher shines a light on the mighty, but little‑known Laurentian Great Lakes freshwater commercial fisheries in new documentary
- Media opportunity: Three early career researchers doing their fieldwork on Sable Island think others can learn from their experiences on the remote North Atlantic island
- Media opportunity: Youth voices at centre of Dalhousie University researcher's examination of mental health programs to determine what supports best meet their needs
- Media opportunity: Dalhousie University researchers address high epilepsy rates and stigma in rural Zambia ahead of International Epilepsy Day
- Media release: Dalhousie University researchers receive $7.5 million for projects that will improve mental health and addictions care for young people, and create healthier communities in Nova Scotia through local collaboration
- Media release: Researchers at Dalhousie University find pregnancy may increase risk of mental illness in people with multiple sclerosis